Detalhe da pesquisa
1.
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
J Antimicrob Chemother
; 71(3): 783-93, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26679250
2.
Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load.
Eur J Immunol
; 44(9): 2802-10, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25042008
3.
Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
AIDS
; 28(11): 1593-602, 2014 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-24865974
4.
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS
; 26(6): 711-20, 2012 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-22301410